Recorded webinars

Recorded webinars

The Danish Diabetes Academy is now offering new ways of mediating knowledge in terms of short online introductory webinars using Adobe Connect with the purpose of introducing a wide range of diabetes related topics. Below you can see the recordings of our previously broadcasted webinars.

  1. Cluster of 4 webinars on MircroRNAs
  2. Cluster of 4 webinars on Getational Diabetes Mellitus
  3. Type 2 Diabetes Phenotypes
  4. Gastrointestinal Dysmotility and Autonomic Neuropathy in T1D
  5. Diabetic Poly-Neuropathy
  6. Fetal Programming  

UNDERSTANDING A BUG'S LIFE IN THE FAT LAND

BROADCASTED ON 7 JULY 2017
by Associate Professor Anand Hardikar, The University of Sydney, Australia

A recording of this webinar will be uploaded soon.

Microbiota residing in/on our bodies are 10-times more than the total number of cells in our body.  The fact that 90% of the cells in our body are bugs makes one think about the potential impact these may have on human physiology.  I will review research in this field and discuss some of the advantages and limitations of some procedures associated with microbiome studies. I will also discuss the potential role of gut biota as well as microRNAs in the epigenetic regulation of insulin gene expression.  This webinar is aimed to help new researchers/students gain a better understanding of the field and develop methodologies to address the role of gut biota in the development of obesity and type 2 diabetes.     

PRIMER ON MOLECULAR BIOMARKERS IN DIABETES

BROADCASTED ON 6 JULY 2017
by Associate Professor Anand Hardikar, The University of Sydney, Australia

A recording of this webinar will be uploaded soon.

Recent years have witnessed growing interest in discovering novel biomarkers of disease progression.  The aim of this webinar is to discuss i) the need for developing new biomarkers in diabetes, ii) the possible approaches to developing microRNA/mRNA-based signatures of disease progression, iii) methodologies for identifying the appropriate platform for assessment and iv) assay designing and validating molecular signature(s). 

MicroRNA quantification 

BROADCASTED ON 21 JUNE 2017
by Dr. Ari Meerson, MIGAL Galilee Research Institute, Israel

The interest in microRNAs as biomarkers and regulators of gene expression has led to a rapid growth in the number of available quantification methods and platforms. This webinar will highlight the various approaches that have been developed, and the following analytical stages will be addressed:

  1. Isolation of microRNAs, including from biofluids
  2. Hypothesis-free miRnome profiling, and the bioinformatic tools useful in the analysis of results
  3. Quantification of specific microRNAs, including considerations of throughput and cost
  4. Localization and dynamics of microRNA expression My hope is that this overview will provide pointers for researchers who are new to the microRNA field

MicroRNAs link obesity and cancer

BROADCASTED ON 21 JUNE 2017
by Dr. Ari Meerson, MIGAL Galilee Research Institute, Israel

Chronic diseases such as obesity, diabetes mellitus and cancer, are leading health problems in developed countries. The broadly correlated risk of these diseases suggests that their pathologies involve similar molecular mechanisms. Several microRNAs are implicated in metabolic dysfunction and also have established roles as oncogenes or tumor suppressors.

The aim of Ari Meerson and his group's research was to identify cancer-relevant microRNAs that 1) respond to metabolic hormone signaling in cultured cells or 2) show altered levels in obese human subjects, and to explore their biological functions, downstream targets and upstream regulation. Three projects in Ari Meerson's lab (2 published and 1 ongoing) is discussed. 

GDM: SOM OBSERVATIONS FROM INDIA

BROADCASTED ON 8 JUNE 2017
by Professor Chittaranjan Yajnik, KEM Hospital Research Centre, Pune, India

India is one of the world capitals of diabetes and GDM. Characteristics of Indian patients are different than those in the western populations. This raises intriguing issues for research. 

LONG TERM OUTCOMES IN GDM PREGNANCIES

BROADCASTED ON 7 JUNE 2017
by Professor Chittaranjan Yajnik, KEM Hospital Research Centre, Pune, India

Obesity, glucose intolerance and  increased CV risk for both mother and the baby. Is this genetic or non-genetic? Are there any ways to prevent these outcomes.

PHARMACOLOGICAL MANAGEMENT OF GDM - IS THERE A PLACE OF ORAL AGENTS?

BROADCASTED ON 7 JUNE 2017
by Visiting Professor David McIntyre, The University of Queensland Faculty of Medicine

Consideration of the role of oral hypoglycemic medications in the treatment of GDM.

APPROACH TO UNIFORM DIAGNOSIS OF GESTATIONAL DIABETES MELLITUS

BROADCASTED ON 30 MAY 2017
by Visiting Professor David McIntyre, The University of Queensland Faculty of Medicine

 

Comparison of international (IADPSG / WHO) and local guidelines for diagnosis of gestational diabetes.

TYPE 2 DIABETES PHENOTYPES

BROADCASTED ON 5 DECEMBER 2016
by Visiting Professor Venkat Narayan, Emory University

GASTROINTESTINAL DYSMOTILITY AND AUTONOMIC NEUROPATHY IN T1D

BROADCASTED ON 17 NOVEMBER 2016
by Visiting Professor Adam Farmer, Keele University

In this webinar Adam Farmer gives an introduction to pathophysiological features of the gastrointestinal complications of diabetes and he discussed the investigations and management of this disorder.    

DIABETIC POLY-NEUROPATHY 

BROADCASTED ON 4 OCTOBER 2016
by Post Doc Páll Karlsson, Aarhus University

In this webinar Pall Karlsson gives an introduction to diabetic polyneuropathy - a common and serious complication of diabetes. He will focus on the relationship between the structure and function of the sensory nerve fibers that give arise to the clinical symptoms. He will also cover his own research, which focuses on finding changes in the nerve fibers that can explain why some patients develop chronic pain while others do not and changes which may even predict the development of pain before the symptoms start to emerge.   

FETAL PROGRAMMING WITH FOCUS ON NUTRITIONAL ASPECTS 

BROADCASTED ON 27 SEPTEMBER 2016 
by Post Doc Ekaterina Maslova, Statens Serums Institut

In this webinar Ekaterina Maslova:

  • provides an introduction to the physiological and epidemiological basis for the fetal origins hypothesis
  • outlines the proposed theories to explain how and why fetal programming occurs
  • addresses some of the criticisms aimed at the hypothesis
  • describes the future directions of the field